Randomized controlled trial comparing operative times between standard and robot-assisted laparoscopic hysterectomy
- PMID: 28099699
- PMCID: PMC5245181
- DOI: 10.1002/ijgo.12001
Randomized controlled trial comparing operative times between standard and robot-assisted laparoscopic hysterectomy
Abstract
Objective: To compare the operative time between robot-assisted laparoscopic hysterectomies and standard laparoscopic hysterectomies.
Methods: A prospective, randomized controlled trial enrolled women aged 18-80 years attending Penn State Hershey Medical Center between April 23 and October 20, 2014 to undergo hysterectomy. Participants were randomized using a random number generator to undergo either robot-assisted or standard laparoscopic hysterectomy. The primary outcome was the total operative time (surgeon incision to surgeon stop, including robot docking time, if applicable). Intention-to-treat analyses were performed and the operative time was compared between the two treatments for non-inferiority, defined as a difference in operative time of no longer than 15 minutes.
Results: There were 72 patients randomized to each treatment arm. The mean operative time was 73.9 minutes (median 67.0 minutes; interquartile range 59.0-83.0 minutes) in the robot-assisted hysterectomy group and 74.9 minutes (median 65.5 minutes; interquartile range 57.0-90.5 minutes) in the standard laparoscopic hysterectomy group. The upper bound of the 95% confidence interval of the difference in operative time was 6.6 minutes, below the 15-minute measure of non-inferiority.
Conclusion: When performed by a surgeon experienced in both techniques, the operative time for robot-assisted laparoscopic hysterectomy was non-inferior to that achieved with standard laparoscopic hysterectomy. CLINICALTRIALS.GOV: NCT02118974.
Keywords: Hysterectomy; Laparoscopic; Minimally invasive; Operative time; Robotic-assisted.
© 2016 International Federation of Gynecology and Obstetrics.
Conflict of interest statement
G.J.H. was a proctor for Ethicon and Intuitive Surgical during the study period. A.R.K. owns stock in Merck. The authors have no other conflicts of interest.
Figures


References
-
- ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2009;114(5):1156–1158. - PubMed
-
- Orady M, Aslanova R, Fidela Paraiso M. Minimally invasive hysterectomy for benign indications. Minerva Ginecol. 2014;66(1):13–21. - PubMed
-
- Advincula AP. Surgical techniques: robot-assisted laparoscopic hysterectomy with the da Vinci surgical system. Int J Med Robot. 2006;2(4):305–311. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous